|
'Guided Missiles' to Treat Cancer
|
10:41 AM |
Apr 5, 2013 |
WSJ.com
|
|
Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures
|
8:50 AM |
Apr 4, 2013 |
PR
|
|
Drug Firms Expand Powers to Recoup Pay
|
7:44 PM |
Apr 3, 2013 |
WSJ.com
|
|
Vanguard Reopens Capital Opportunity Fund --- That's a Contrarian Opportunity
|
10:40 AM |
Apr 3, 2013 |
Barrons.com
|
|
Morning Research on Amgen, Affymax, Vertex Pharma, Questcor Pharma, and Repros Therapeutics
|
8:01 AM |
Apr 1, 2013 |
PR
|
|
Critical Alerts For Las Vegas Sands, Amgen, Edwards Lifesciences, Valeant Pharmaceuticals, and China Mobile Released By InvestorsObserver
|
9:31 AM |
Mar 21, 2013 |
PR
|
|
UPDATE: Model N Shares Jump After Tech Firm's IPO
|
11:18 AM |
Mar 20, 2013 |
Dow Jones Global News Select
|
|
Model N Shares Rise After IPO
|
10:20 AM |
Mar 20, 2013 |
Dow Jones Global News Select
|
|
Amgen Announces Top-Line Results Of Phase 3 -2-
|
6:04 PM |
Mar 19, 2013 |
PR
|
|
Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma
|
6:04 PM |
Mar 19, 2013 |
PR
|
|
Innovative Product Portfolios Ride Commercialization & Global Expansion - Research Report on Amgen, Onyx Pharmaceuticals, Alexion Pharmaceuticals, BioMarin Pharmaceutical and Incyte
|
8:01 AM |
Mar 18, 2013 |
PR
|
|
Here's What a Fidelity ETF Might Look Like
|
12:15 PM |
Mar 14, 2013 |
Barrons.com
|
|
A Forward Look, the Year Ahead - Research Report on Amgen, Inc., Bristol Myers Squibb Co., Ann Inc., Limited Brands, Inc. and AMETEK, Inc.
|
8:02 AM |
Mar 14, 2013 |
PR
|
|
Merck Names New Research Chief; Stock Drops
|
2:45 PM |
Mar 7, 2013 |
Barrons.com
|
|
Merck Names Former Amgen Executive as Research Chief
|
10:57 AM |
Mar 7, 2013 |
WSJ.com
|
|
BioMarin Pharma, Amgen, Sarepta Therapeutics, Chelsea Therapeutics Intl., and Theravance Early Briefing and Review
|
8:02 AM |
Mar 7, 2013 |
PR
|
|
Celgene Drug Results Fall Short of Earlier Trial
|
12:49 PM |
Mar 2, 2013 |
WSJ.com
|
|
High Court Allows Amgen Suit
|
5:25 PM |
Feb 27, 2013 |
WSJ.com
|
|
Amgen Fraud Suit to Proceed as Class-Action
|
4:37 PM |
Feb 27, 2013 |
WSJ.com
|
|
Copies of Costly Biotech Drugs Face Delays
|
6:05 PM |
Feb 26, 2013 |
WSJ.com
|
PLAY
PLAY
